IBDEI1ES ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24979,0)
 ;;=553.21^^144^1553^18
 ;;^UTILITY(U,$J,358.3,24979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24979,1,2,0)
 ;;=2^553.21
 ;;^UTILITY(U,$J,358.3,24979,1,5,0)
 ;;=5^HERNIA,INCISIONAL
 ;;^UTILITY(U,$J,358.3,24979,2)
 ;;=^270246
 ;;^UTILITY(U,$J,358.3,24980,0)
 ;;=550.92^^144^1553^19
 ;;^UTILITY(U,$J,358.3,24980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24980,1,2,0)
 ;;=2^550.92
 ;;^UTILITY(U,$J,358.3,24980,1,5,0)
 ;;=5^HERNIA,INGUINAL,BILAT
 ;;^UTILITY(U,$J,358.3,24980,2)
 ;;=^270212
 ;;^UTILITY(U,$J,358.3,24981,0)
 ;;=550.90^^144^1553^20
 ;;^UTILITY(U,$J,358.3,24981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24981,1,2,0)
 ;;=2^550.90
 ;;^UTILITY(U,$J,358.3,24981,1,5,0)
 ;;=5^HERNIA,INGUINAL,UNILAT
 ;;^UTILITY(U,$J,358.3,24981,2)
 ;;=^63302
 ;;^UTILITY(U,$J,358.3,24982,0)
 ;;=553.1^^144^1553^21
 ;;^UTILITY(U,$J,358.3,24982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24982,1,2,0)
 ;;=2^553.1
 ;;^UTILITY(U,$J,358.3,24982,1,5,0)
 ;;=5^HERNIA,UMBILICAL
 ;;^UTILITY(U,$J,358.3,24982,2)
 ;;=^123475
 ;;^UTILITY(U,$J,358.3,24983,0)
 ;;=722.2^^144^1553^22
 ;;^UTILITY(U,$J,358.3,24983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24983,1,2,0)
 ;;=2^722.2
 ;;^UTILITY(U,$J,358.3,24983,1,5,0)
 ;;=5^HERNIATED DISC
 ;;^UTILITY(U,$J,358.3,24983,2)
 ;;=^35649
 ;;^UTILITY(U,$J,358.3,24984,0)
 ;;=053.9^^144^1553^23
 ;;^UTILITY(U,$J,358.3,24984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24984,1,2,0)
 ;;=2^053.9
 ;;^UTILITY(U,$J,358.3,24984,1,5,0)
 ;;=5^HERPES ZOSTER NOS
 ;;^UTILITY(U,$J,358.3,24984,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,24985,0)
 ;;=V66.7^^144^1553^25
 ;;^UTILITY(U,$J,358.3,24985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24985,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,24985,1,5,0)
 ;;=5^HOSPICE CARE
 ;;^UTILITY(U,$J,358.3,24985,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,24986,0)
 ;;=V08.^^144^1553^24
 ;;^UTILITY(U,$J,358.3,24986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24986,1,2,0)
 ;;=2^V08.
 ;;^UTILITY(U,$J,358.3,24986,1,5,0)
 ;;=5^HIV,ASYMPTOMATIC
 ;;^UTILITY(U,$J,358.3,24986,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,24987,0)
 ;;=603.9^^144^1553^26
 ;;^UTILITY(U,$J,358.3,24987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24987,1,2,0)
 ;;=2^603.9
 ;;^UTILITY(U,$J,358.3,24987,1,5,0)
 ;;=5^HYDROCELE NOS
 ;;^UTILITY(U,$J,358.3,24987,2)
 ;;=^59548
 ;;^UTILITY(U,$J,358.3,24988,0)
 ;;=272.0^^144^1553^27
 ;;^UTILITY(U,$J,358.3,24988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24988,1,2,0)
 ;;=2^272.0
 ;;^UTILITY(U,$J,358.3,24988,1,5,0)
 ;;=5^HYPERCHOLESTEROLEM
 ;;^UTILITY(U,$J,358.3,24988,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,24989,0)
 ;;=272.4^^144^1553^28
 ;;^UTILITY(U,$J,358.3,24989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24989,1,2,0)
 ;;=2^272.4
 ;;^UTILITY(U,$J,358.3,24989,1,5,0)
 ;;=5^HYPERLIPIDEMIA NEC/NOS
 ;;^UTILITY(U,$J,358.3,24989,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,24990,0)
 ;;=276.7^^144^1553^29
 ;;^UTILITY(U,$J,358.3,24990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24990,1,2,0)
 ;;=2^276.7
 ;;^UTILITY(U,$J,358.3,24990,1,5,0)
 ;;=5^HYPERPOTASSEMIA
 ;;^UTILITY(U,$J,358.3,24990,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,24991,0)
 ;;=401.9^^144^1553^30
 ;;^UTILITY(U,$J,358.3,24991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24991,1,2,0)
 ;;=2^401.9
 ;;^UTILITY(U,$J,358.3,24991,1,5,0)
 ;;=5^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,24991,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,24992,0)
 ;;=401.1^^144^1553^31
 ;;^UTILITY(U,$J,358.3,24992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24992,1,2,0)
 ;;=2^401.1
 ;;^UTILITY(U,$J,358.3,24992,1,5,0)
 ;;=5^HYPERTENSION,BENIGN
 ;;
 ;;$END ROU IBDEI1ES
